Drug interactions
Bumetanide + Indacaterol-glycopyrronium
Severity: Moderate
Bumetanide and Indacaterol-glycopyrronium: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Loop diuretics lower serum potassium, and beta-2 agonists can further lower it by driving potassium into cells. Hypokalemia may promote arrhythmias, especially in patients with heart disease or hypoxia.
What this interaction means in plain words
Bumetanide and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bumetanide belongs to Cardiovascular; Indacaterol-glycopyrronium belongs to Respiratory.
Why it happens
Additive hypokalemia from renal potassium loss and beta-2-mediated intracellular potassium shift.
What to do
Monitor serum potassium and magnesium, especially at initiation and with dose changes. Supplement potassium as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bumetanide and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Bumetanide
Frequently asked questions
Can I take Bumetanide with Indacaterol-glycopyrronium?
MediHelp rates the interaction as moderate. Bumetanide and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Loop diuretics lower serum potassium, and beta-2 agonists can further lower it by driving potassium into cells. Hypokalemia may promote arrhythmias, especially in patients with heart disease or hypoxia.
How serious is the interaction between Bumetanide and Indacaterol-glycopyrronium?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and magnesium, especially at initiation and with dose changes. Supplement potassium as needed.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
